US20130237906A1 - Liquid crystal polymer-based electro-optrode neural interface, and method for producing same - Google Patents
Liquid crystal polymer-based electro-optrode neural interface, and method for producing same Download PDFInfo
- Publication number
- US20130237906A1 US20130237906A1 US13/880,421 US201113880421A US2013237906A1 US 20130237906 A1 US20130237906 A1 US 20130237906A1 US 201113880421 A US201113880421 A US 201113880421A US 2013237906 A1 US2013237906 A1 US 2013237906A1
- Authority
- US
- United States
- Prior art keywords
- lcp
- optrode
- electro
- optical fiber
- electrode
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0526—Head electrodes
- A61N1/0529—Electrodes for brain stimulation
- A61N1/0534—Electrodes for deep brain stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6867—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive specially adapted to be attached or implanted in a specific body part
- A61B5/6868—Brain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
- A61B5/316—Modalities, i.e. specific diagnostic methods
- A61B5/388—Nerve conduction study, e.g. detecting action potential of peripheral nerves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0551—Spinal or peripheral nerve electrodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0622—Optical stimulation for exciting neural tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B1/00—Instruments for performing medical examinations of the interior of cavities or tubes of the body by visual or photographical inspection, e.g. endoscopes; Illuminating arrangements therefor
- A61B1/00163—Optical arrangements
- A61B1/00165—Optical arrangements with light-conductive means, e.g. fibre optics
- A61B1/0017—Details of single optical fibres, e.g. material or cladding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0209—Special features of electrodes classified in A61B5/24, A61B5/25, A61B5/283, A61B5/291, A61B5/296, A61B5/053
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36014—External stimulators, e.g. with patch electrodes
- A61N1/36025—External stimulators, e.g. with patch electrodes for treating a mental or cerebral condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0601—Apparatus for use inside the body
- A61N2005/0612—Apparatus for use inside the body using probes penetrating tissue; interstitial probes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T156/00—Adhesive bonding and miscellaneous chemical manufacture
- Y10T156/10—Methods of surface bonding and/or assembly therefor
- Y10T156/1052—Methods of surface bonding and/or assembly therefor with cutting, punching, tearing or severing
Definitions
- the present invention relates to a neural interface which is inserted into a body and a method of manufacturing the same and, more particularly, to a liquid crystal polymer-based electro-optrode neural interface including an electrode and an optrode integrated together, and to a method of manufacturing the same.
- neural interfaces such as electrodes and optrodes for stimulating deep brain regions or measuring neural signals from deep brain regions are responsible for very important functions in neural prostheses such as cochlear implants, artificial thin-films, deep brain stimulators, etc., or in neuroscience research including biosignal measurement, etc.
- the neural interfaces are used to stimulate neural tissue of animals, including human beings, or to record neural signals or biosignals generated from neutral tissue. Neural stimulation or neural signal recording is carried out using an electrical process or an optical process.
- Electrodes are mainly manufactured using semiconductor materials such as silicon, SOT (Silicon-on-Insulator), etc., or metal materials such as platinum, tungsten, etc., through which potential differences of cells are induced or recorded (see Citation Document [1]).
- Optrodes are made using transparent materials through which light passes, and cells may be stimulated with light using techniques such as optogenetics, etc. (see Citation Document [2]).
- optrodes may record neural signals of cells in response to light, such as surface Plasmon, changes in transmittance of near infrared rays, etc. (see Citation Documents [3] and [4]).
- materials for use in implantable techniques such as neural interfaces should be based on biocompatibile materials or should be composed exclusively of biocompatibile materials.
- a material for use in manufacturing an optical neural interface has to have rigidity.
- electrodes currently used in neural prosthetic devices are problematic in terms of very high production costs because a batch process which may decrease the production costs, such as a semiconductor process, is not used.
- DBS Deep Brain Simulator
- MRI scanning and ATLAS anatomical map of the brain
- MER Micro Electrode Recording
- stimulation electrodes are inserted using a stereotaxic operation device before electrode insertion for DES.
- the neural signals are recorded depending on the inserted position to check the correct location of the electrode, after which the micro electrode for recording a neural signal is removed, and a stimulation electrode is inserted again.
- insertion methods without MER using MRI information and ATLAS anatomical map of the brain.
- Methods using anatomical map information of the brain are used to determine the final insertion position via approximate coordinate systems based on MRI or C-arm, thus shortening the operation time to thereby reduce the loss of body fluids, but it is very difficult to exactly position the stimulation electrode due to minor shifting of the brain during the operation.
- the stimulus signal is directly recorded, separately from the neural signal in response to the cell stimulation, which is called an artifact signal.
- This signal is formed immediately after the stimulation and has a magnitude greater than that of the neural signal. To show the response immediately after the stimulation, an additional process for removing the artifact signal is required.
- the neural interface device to be inserted in vivo should be based on a biocompatible material and should have strength adapted to be inserted into a brain. Also, this interface should be able to be inexpensively manufactured using a batch process from the point of view that it would have a great influence on the popularization and market expansion of neural prosthetic devices.
- the electrode used in the neural interface device an artifact signal in response to the electrical stimulation is recorded, and thus problems due to the need for an additional process for actually separating the neural signal and an additional reference electrode, and due to reduced effects owing to generation of gliosis, should be solved.
- rapid operations should become possible, compared to conventional stereotaxic operations which require a long operation time because of MRI or CT scanning during the operation.
- a liquid crystal polymer has strength adapted to be inserted into a brain, is biocompatible, and may be subjected to a batch process thus reducing the production cost (see Citation Documents [6] and [7]), and the stereotaxic operation may be conducted using the combined optrode and electrode and thus the operation position may be rapidly checked thereby reducing the operation time, effects due to gliosis may be reduced by the optrode as light may pass through cells to some extent (see Citation Document [9]), and also the case where the neural signal is detected with light is not affected by the artifact signal, thus simplifying the post-treatment procedure (see Citation Documents [3] and [4]).
- an object of the present invention is to provide a liquid crystal polymer (LCP)-based electro-optrode neural interface having integrated electrode and optrode and a method of manufacturing the same.
- LCP liquid crystal polymer
- design and fabrication techniques of electrodes for stimulating deep brain regions enable electrode design in which an optical technique for recording a neural signal without an artifact signal and an electrode technique for electrically recording a neural signal are embodied on a single electrode.
- LCP liquid crystal polymer
- a semiconductor process enables the formation of various kinds of electrode site designs and multifunctional electrodes including fluidic channel, etc., and also enables the development for a coupling method with an optical fiber to achieve an optical technique.
- an integrated electrode can be provided in such a manner that the optical fiber is surrounded with an adhesive sheet in a thermoplastic thin-film form.
- a variety of neural signal recording methods and stimulation methods can be applied depending on needs, and the neural signal can be more exactly recorded using electrical and optical recording methods.
- continuous disease treatment is possible using electrical stimulation as in conventional electrodes and optical stimulation as in specific cases such as generation of gliosis.
- MER and stimulation electrode insertion can be completed using one electrode operation, and the operation time can be shortened, thus reducing burdens on patients and operators, and also the electrode position can be monitored in real time, making it possible to perform a more exact electrode insertion operation.
- FIG. 1 is a perspective view illustrating an electro-optrode neural interface according to an embodiment of the present invention
- FIG. 2 is a cross-sectional view taken along the line II-II of FIG. 1 illustrating the electro-optrode neural interface
- FIG. 3 is a perspective view illustrating the electrode layer configuration of the electro-optrode neural interface of FIG. 1 ;
- FIGS. 4 a to 4 g are a flowchart illustrating a process of manufacturing the electro-optrode neural interface of FIG. 1 ;
- FIG. 5 is a flowchart illustrating another process of manufacturing the electro-optrode neural interface of FIG. 1 ;
- FIG. 6 is a perspective view illustrating the entire configuration of an electro-optrode neural interface according to another embodiment of the present invention.
- FIG. 7 is a flowchart illustrating a process of manufacturing the electro-optrode neural interface of FIG. 6 .
- FIG. 1 is a perspective view illustrating an electro-optrode neural interface according to an embodiment of the present invention
- FIG. 2 is a cross-sectional view taken along the line II-II of FIG. 1 illustrating the electro-optrode neural interface
- FIG. 3 is a perspective view illustrating the electrode layer configuration of the electro-optrode neural interface of FIG. 1 .
- the electro-optrode neural interface 100 is connected to an implanted device (not shown), so that biosignals collected in vivo are transferred to the implanted device, and the implanted device executes signal processing, storage and analysis of the transferred biosignals and sends the obtained results to the outside.
- the electro-optrode neural interface 100 includes an optical fiber 10 which is extended so as to be insertable into the body and is positioned at a core thereof so as to form an optical electrode portion, an adhesive sheet 20 surrounding the optical fiber 10 , an LCP electrode layer 30 wound on the optical fiber 10 by means of the adhesive sheet 20 and pre-manufactured using a semiconductor process, and a stimulation electrode site 40 attached to the adhesive sheet 20 at a distal end of the LCP electrode layer 30 .
- the LCP electrode layer 30 is made of thermoplastic low-temperature LCP or high-temperature LCP, and may form a multi-channel electrode using a semiconductor process or a MEMS process.
- the LCP electrode layer 30 is formed with the multi-channel electrode, information about not only one place, but of various places in viva may be obtained from respective electrodes.
- the adhesive sheet 20 functions to adhere or fix the LCP electrode layer 30 to the optical fiber 10 , and includes a low-temperature LCP film or polyurethane having adhesiveness and biocompatibility.
- the adhesive sheet 20 and the LCP electrode layer 30 are coupled to each other to form an LCP sample 50 .
- the LCP electrode layer 30 may be omitted, and thus the diameter of the electro-optrode neural interface may decrease.
- the optical fiber 10 which is a part of the optical electrode, may perform optical neural signal measurement or stimulation, and acts as a lens such as an endoscope upon operation so that the interface is inserted into the body while avoiding cerebral blood vessels. Accordingly, a special optical fiber which withstands a temperature of 280 ⁇ 290° C., for example, an optical fiber made of polyimide, polyurethane, etc., is preferably used.
- the end of the optical fiber 10 may have a hemispherical shape as illustrated in FIG. 1 , but may have a variety of shapes such as a conical shape, a flat surface, etc., depending on the cutting and processing type.
- the stimulation electrode site 40 is made of a metal, for example, Au or Pt, having a thickness of hundreds of nanometers through which an electrical stimulation waveform passes, and executes current/optical signal recording and electrical stimulation.
- the stimulation electrode site 40 has a fluidic channel 42 configured to inject a drug into the region in which the electrode is inserted.
- the electro-optrode neural interface according to the present invention is formed by combining a micro electrode for recording a neural signal and a stimulation electrode, has high long-term stability, and is configured such that a neural electrode is formed using the LCP film 50 comprising the LCP electrode layer and the adhesive sheet 20 integrated with each other, and the optical fiber 10 is surrounded therewith.
- the neural electrode using the LCP film 50 comprising the LCP electrode layer and the adhesive sheet 20 integrated with each other plays a role in recording the neural signal and performing multiple functions including electrical stimulation, drug delivery, etc., and the optical fiber 10 is responsible for recording the neural signal and for the function of the stimulation electrode.
- the electrode insertion operation need only be completed once, thus shortening the operation time.
- the electro-optrode neural interface according to the present invention is able to use the optical fiber as an endoscope and thus whether the cerebral blood vessel is present or not may be observed with the naked eye in real time using the overall reflective property of the optical fiber. Also, when the integration of peripheral circuits is accomplished, the electro-optrode neural interface according to the present invention enables the direction of electrode entry to be changed variously like in the case of currently used endoscopes, and may thus be developed into a future electrode that is inserted up to the stimulus position while avoiding causing damage to cerebral blood vessels, in lieu of the linear electrode insertion which is currently mainly performed. Ultimately, difficulties in monitoring the position of the electrode are solved.
- the stimulation electrode of the invention is an optical electrode using an optical technique and thus stimulation of tissue using the optical electrode, namely, optical stimulation, is possible even when gliosis surrounds the electrode, thereby solving problems of gliosis caused by the immune response, etc.
- an LCP electrode layer 30 which is pre-manufactured in a long tape form, an adhesive sheet 20 , and an optical fiber 10 that withstands a temperature of about 300° C. are prepared.
- the pre-manufactured LCP electrode layer 30 may be integrated with the adhesive sheet 20 using a semiconductor process, and the LCP electrode layer and the adhesive sheet, which are integrated with each other, refer to an LCP sample 50 .
- the manufacturing method using the LCP sample 50 is described.
- the LCP sample 50 is densely wound on the optical fiber 10 , and the optical fiber 10 is mechanically held to a cylindrical optical fiber fixer 60 .
- the optical fiber 10 is held by being pulled at a predetermined tension so that pressure applied to the LCP sample 50 is maintained constant.
- the prepared LCP sample 50 is placed in a metal mold 70 and heated while being rotated.
- the heating temperature is set so that the temperature applied to the LCP sample 50 is about 275 ⁇ 280° C., and the LCP sample 50 is rotated in non-contact type so as not to come into direct contact with the metal mold 70 .
- This is intended to prevent thermal deformation of the optical fiber 10 , which is unnecessary and undesirable.
- the reference numeral 72 is an alignment pin of the LCP 50 and the metal mold 70 .
- the prepared LCP sample 50 is placed in a metal mold 70 and heated.
- a repulsive layer 80 made of Teflon is disposed between the optical fiber 10 and the metal mold 70 in order to prevent the electrode layer from being melted and attached to the metal mold 70 during the heating.
- the heating temperature is set so that the temperature applied to the LCP sample 50 is about 275 ⁇ 280° C. This case is performed when heat resistance of the optical fiber 10 is very high, and is advantageous because the process time is short and the roughness of the entire electrode is low.
- a mixed heating process including the non-contact type and the contact type may be performed.
- the mixed heating process is performed by disposing a repulsive layer 80 between the LCP sample 50 and the metal mold 70 and periodically tapping the LCP sample 50 by the metal mold 70 at a regular temporal interval, that is, repeatedly applying predetermined pressure.
- the LCP sample 50 is heated while being rotated in the metal mold 70 .
- the heating temperature is set so that the temperature applied to the LCP sample 50 is about 275 ⁇ 280° C.
- the thermal deformation of the optical fiber 10 which is unnecessary and undesirable, is prevented.
- the above-mentioned heating process enables the LCP electrode layer to be melted by means of heat and pressure so as to attach the adhesive sheet and the optical fiber to each other. This refers to lamination. While the LCP electrode layer is melted under predetermined temperature and pressure conditions, it is coupled to the optical fiber.
- the tip of the optical fiber 10 which is unnecessarily long, is cut using a fiber cutter, thus manufacturing the electro-optrode neural interface 100 according to the present invention.
- a stimulation electrode site 40 is attached to the manufactured electro-optrode neural interface 100 .
- the portion where the optical fiber 10 is exposed is responsible for recording the neural signal using the optical signal, checking for the presence of the cerebral blood vessel upon an electrode insertion operation to execute optical simulation, and measuring the reflectance of the optical signal during the insertion, so that the position of the inserted electro-optrode neural interface may be monitored in real time. Even when gliosis occurs, deep brain stimulation effects may be induced via optical stimulation.
- the stimulation electrode site 40 wherein the electrical signal is recorded and the electrical stimulation is executed may have multiple channels depending on the type of design, and impedance or charge injection limit may become diversified depending on the material for the site.
- FIG. 5 illustrates another process of manufacturing the electro-optrode neural interface.
- a prepared LCP sample 50 is disposed at upper and lower positions of an optical fiber 10 , and a repulsive layer 80 is disposed between the optical fiber 10 and a metal mold 70 , and the resulting sample is placed in the metal mold 70 .
- the metal mold 70 is heated. Accordingly, the LCP sample 50 at the upper and lower positions of the optical fiber 10 is fused and transformed so as to surround the optical fiber 10 . During the heating, the transformation of the LCP sample 50 , that is, low-temperature LCP material is induced at 270° C. for a predetermined period of time, after which heating is carried out under pressure so that the heating temperature is about 275 ⁇ 280° C.
- FIG. 6 is a perspective view illustrating an electro-optrode neural interface according to another embodiment of the present invention.
- the electro-optrode neural interface 200 according to another embodiment of the present invention includes a substrate portion 210 made of high-temperature or low-temperature LCP, electrode portions 220 formed on the upper side of the substrate portion 210 and spaced apart from each other to collect biosignals and to transfer the collected biosignals, and an optrode portion 240 formed on the upper side of the substrate portion 210 between the electrode portions 220 to form an optical electrode portion.
- the electro-optrode interface 200 is connected to an implanted device (not shown), so that biosignals collected in vivo are transferred to the implanted device, and the implanted device performs signal processing, storage and analysis of the transferred biosignals and sends the obtained results to the outside.
- the electrode portions 220 are formed by patterning a metal such as Au on the substrate portion 210 .
- the electrode portions 220 may be formed with a multi-channel electrode, or may be formed using a MEMS process.
- the optrode portion 240 is formed by patterning a patternable transparent material, that is, a photopolymer such as SU-8, and may be formed to be a desired size, enables light to pass therethrough, and may be formed using a MEMS process.
- a patternable transparent material that is, a photopolymer such as SU-8
- the substrate portion 210 functions to protect the electrode portions 220 and the optrode portion 240 , and is made of LCP, especially low-temperature LCP.
- the electro-optrode neural interface 200 further includes a cover portion 260 layered on the substrate portion 210 so as to protect the electrode portions 220 and the optrode portion 240 .
- the cover portion 260 is formed using hot pressing on the substrate portion 210 , and is made of high-temperature or low-temperature LCP, especially low-temperature LCP, as in the substrate portion 210 .
- an adhesive layer of low-temperature LCP may be additionally required between the substrate portion 210 and the cover portion 260 .
- the electro-optrode neural interface according to another embodiment of the present invention is manufactured as illustrated in FIG. 7 .
- the upper side of a substrate portion 210 having an approximate rectangular shape is subjected to Au patterning, thus forming electrode portions 220 extended in a longitudinal direction of the substrate portion 210 and spaced apart from each other. Subsequently, the space between the electrode portions 220 is patterned with a photopolymer such as SU-8 so as not to overlap with the electrode portions 220 formed on the substrate portion 210 , thus forming an optrode portion 240 .
- a photopolymer such as SU-8
- a cover portion 260 made of LCP is placed on the substrate portion 210 having the electrode portions 220 and the optrode portion 240 formed thereon and then laminated. As such, the cover portion 260 is laminated so as to provide exposure portions 242 and 246 which expose parts of the electrode portions 220 and the optrode portion 240 .
- the exposure portion 242 is formed close to the insertion direction of the body, through which biosignals are collected.
- the exposure portion 246 which is located opposite to the exposure portion 242 , functions to transfer the biosignals collected by the exposure portion 242 to an implanted device (not shown).
- a part of the substrate portion 210 other than the electrode portions 220 and the optrode portion 240 formed on the substrate portion 210 laminated with the cover portion 260 is cut using a laser, thus manufacturing the electro-optrode neural interface 200 as illustrated in FIG. 6 .
- alignment holes 262 are formed in the interface, and the feed-through 280 is connected using the alignment holes 262 .
- the feed-through 280 includes an electrical cable 282 so that the electrode portions 220 are connected to an electrical circuit element of the implanted device, and the optrode portion 240 is connected to a measurement element of the implanted device which measures the generation of an optical signal.
- the feed-through is coated with an insulating material so as to prevent it from being exposed to the outside.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Surgery (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Cardiology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychology (AREA)
- Optics & Photonics (AREA)
- Child & Adolescent Psychology (AREA)
- Developmental Disabilities (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Social Psychology (AREA)
- Electrotherapy Devices (AREA)
- Liquid Crystal (AREA)
- Endoscopes (AREA)
- Prostheses (AREA)
Abstract
The invention relates to an electro-optrode neural interface, comprising an optical fiber which is elongated so as to be insertable into a body, and which is located at a core portion so as to form an optical electrode portion, and a liquid crystal polymer(LCP) sample encircling the optical fiber. The LCP sample has an adhesive sheet, and an LCP electrode layer encircling the adhesive sheet, wherein the adhesive sheet and the LCP electrode layer are coupled to each other. The electro-optrode neural interface is formed by combining into a single unit, an electrical interface in which an electrode for stimulating deep brain or measuring neural signals from deep brain is arranged in a liquid crystal polymet and an optical interface such as an optical fiber, a waveguide and an endoscope. The electro-optrode interface of the present invention may enable an electro-optrode to be inserted into a body which electrically or optically monitoring the position of the electro-optrode in real time, and may be mass producted.
Description
- The present invention relates to a neural interface which is inserted into a body and a method of manufacturing the same and, more particularly, to a liquid crystal polymer-based electro-optrode neural interface including an electrode and an optrode integrated together, and to a method of manufacturing the same.
- As is well known in the art, neural interfaces such as electrodes and optrodes for stimulating deep brain regions or measuring neural signals from deep brain regions are responsible for very important functions in neural prostheses such as cochlear implants, artificial thin-films, deep brain stimulators, etc., or in neuroscience research including biosignal measurement, etc. The neural interfaces are used to stimulate neural tissue of animals, including human beings, or to record neural signals or biosignals generated from neutral tissue. Neural stimulation or neural signal recording is carried out using an electrical process or an optical process.
- Electrodes are mainly manufactured using semiconductor materials such as silicon, SOT (Silicon-on-Insulator), etc., or metal materials such as platinum, tungsten, etc., through which potential differences of cells are induced or recorded (see Citation Document [1]).
- Optrodes are made using transparent materials through which light passes, and cells may be stimulated with light using techniques such as optogenetics, etc. (see Citation Document [2]).
- Also, optrodes may record neural signals of cells in response to light, such as surface Plasmon, changes in transmittance of near infrared rays, etc. (see Citation Documents [3] and [4]).
- However, conventional materials for electrodes or optrodes have mechanical properties which deteriorate easily, such as in silicon, or have poor rigidity making them unsuitable for use in a brain and thus requiring additional supports. Hence, such materials are mostly limited in applications to implantable neural interfaces, and methods using supports, etc., should be devised (see Citation Document [5]).
- Also, materials for use in implantable techniques such as neural interfaces should be based on biocompatibile materials or should be composed exclusively of biocompatibile materials. In the case where a neural interface is applied to a deep brain region, because there should be no undesirable effects caused by the support in the course of signal transmission via the neural interface, a material for use in manufacturing an optical neural interface has to have rigidity. Furthermore, electrodes currently used in neural prosthetic devices are problematic in terms of very high production costs because a batch process which may decrease the production costs, such as a semiconductor process, is not used.
- Because materials for neural interfaces of neural prosthetic devices, to which a batch process may be applied in future, are sufficiently competitive, those having strength adapted to be inserted into a brain, being biocompatible and able to decrease the production costs using a batch process are advantageously required.
- However, most conventional techniques concerning electrodes or optrodes have been separately studied and tested. In some research groups, prior research into combining these two techniques to construct neural interfaces in vitro was conducted, but research in vivo has not yet been introduced.
- Also, when combinations of optrodes and electrodes are applied to stereotaxic operation, it will be expected that the operation position may be rapidly checked, thus shortening the operation time and reducing effects caused by gliosis due to immune responses and effects of artifact signals by stimulation, but neural interfaces having combined optrodes and electrodes are not structures that can be applied to stereotaxic operation (see Citation Document [8]).
- For example, in the case of an electrode insertion operation for DBS (Deep Brain Simulator), it is conventionally conducted in such a manner that the insertion position is checked using MRI scanning and ATLAS (anatomical map of the brain) before the electrode insertion operation, and the operation is carried out using stereotaxic operation equipment.
- However, it is difficult to execute the operation because of diverse factors including different brain positions or unique brain structures in each person. To solve such problems, methods wherein neural signals are recorded using MER (Micro Electrode Recording) and then stimulation electrodes are inserted are being mainly adopted. In these methods, a micro electrode for recording a neural signal is inserted using a stereotaxic operation device before electrode insertion for DES. The neural signals are recorded depending on the inserted position to check the correct location of the electrode, after which the micro electrode for recording a neural signal is removed, and a stimulation electrode is inserted again. This is because, upon puncturing of the skull to form a bur hole, the pressure of the skull changes and the spinal fluid of the brain flows out of the brain, and thus there occurs a shift in which the position of the brain is changed and is different than it would be during MRI scanning.
- However this method has problems, as follows. {circle around (1)} The operation time is lengthened, undesirably increasing loss of body fluids including the spinal fluid of the brain, blood, etc. {circle around (2)} Two kinds of electrodes are alternately inserted, undesirably increasing the risk of injury to cerebral blood vessels (the recording electrode has a smaller diameter than the stimulation electrode). {circle around (3)} The insertion position of the stimulation electrode is adjusted to a different position, instead of the insertion route of the recording electrode, unnecessarily causing damage to the brain tissue.
- Unlike this, there are proposed insertion methods without MER using MRI information and ATLAS (anatomical map of the brain). Methods using anatomical map information of the brain are used to determine the final insertion position via approximate coordinate systems based on MRI or C-arm, thus shortening the operation time to thereby reduce the loss of body fluids, but it is very difficult to exactly position the stimulation electrode due to minor shifting of the brain during the operation.
- When a specific external object is implanted in vivo, there occurs gliosis in which the brain tissue encloses the electrode recognized as an impurity due to the immune response. In this case, transmission of a stimulus electrical signal to the tissue to be stimulated by the electrode may become problematic, thus reducing stimulation effects and therapeutic effects. Hence, in order to provide appropriate stimulation effects, there may occur a situation in which the electrode insertion operation should be carried out again at an alternative position, undesirably increasing a burden on a patient. In the case of the electrode inserted into the brain, all of a series of procedures, from MRI scanning to the insertion operation, should be undesirably conducted again.
- Finally in the case where electrical stimulation is applied to cells and the neural signal is recorded with the electrode, the stimulus signal is directly recorded, separately from the neural signal in response to the cell stimulation, which is called an artifact signal. This signal is formed immediately after the stimulation and has a magnitude greater than that of the neural signal. To show the response immediately after the stimulation, an additional process for removing the artifact signal is required.
- As mentioned above, the neural interface device to be inserted in vivo should be based on a biocompatible material and should have strength adapted to be inserted into a brain. Also, this interface should be able to be inexpensively manufactured using a batch process from the point of view that it would have a great influence on the popularization and market expansion of neural prosthetic devices. In the case of the electrode used in the neural interface device, an artifact signal in response to the electrical stimulation is recorded, and thus problems due to the need for an additional process for actually separating the neural signal and an additional reference electrode, and due to reduced effects owing to generation of gliosis, should be solved. Moreover, rapid operations should become possible, compared to conventional stereotaxic operations which require a long operation time because of MRI or CT scanning during the operation.
- The present inventors have found that a liquid crystal polymer has strength adapted to be inserted into a brain, is biocompatible, and may be subjected to a batch process thus reducing the production cost (see Citation Documents [6] and [7]), and the stereotaxic operation may be conducted using the combined optrode and electrode and thus the operation position may be rapidly checked thereby reducing the operation time, effects due to gliosis may be reduced by the optrode as light may pass through cells to some extent (see Citation Document [9]), and also the case where the neural signal is detected with light is not affected by the artifact signal, thus simplifying the post-treatment procedure (see Citation Documents [3] and [4]).
-
- [1] U.S. Pat. No. 6,644,552 (Registration date: Nov. 4, 2003)
- [2] Korean Unexamined Patent Application No. 2010-0081862 (Laid-open date: Jul. 15, 2010)
- [3] Korean Unexamined Patent Application No. 2010-0056876 (Laid-open date: May 28, 2010)
- [4] Korean Unexamined Patent Application No. 2010-0056872 (Laid-open date: May 28, 2010)
- [5] Korean Unexamined Patent Application No. 2010-0010714 (Laid-open date: Feb. 2, 2010)
-
- [1] “A High-Yield Fabrication Process for Silicon Neural Probes”, Seung Jae Oh, Jong Keun Song, Jin Won Kim, and Sung June Kim, IEEE Transactions on Biomedical Engineering, Vol. 53, no. 2, pp. 351-354, February 2006.
- [2] “Next-generation optical technologies for illuminating genetically targeted brain circuits”. Deisseroth K, Feng G, Majewska A K, Miesenbock G, Ting A, Schnitzer M J, J. Neurosci. 26 (41): 10380-10386, October 2006.
- [3] “Spectrum measurement of fast optical signal of neural activity in brain tissue and its theoretical origin”, Jonghwan Lee and Sung June Kim, NeuroImage, Vol. 51, no. 2, pp. 713-722, 2010.
- [4] “Optical Measurement of Neural Activity Using Surface Plasmon Resonance”, Shin Ae Kim, Kyung Min Byun, Jonghwan Lee, Jung Hoon Kim, Dong-Ghi Albert Kim, Hyoungwon Baac, Michael L. Shuler, and Sung June Kim, Optics Letters, Vol. 33, no. 9, pp. 914-916, May. 2008.
- [5] “Polyimide based neural implants with stiffness improvement”, Keekeun Lee, Amarjit Singh, Jiping He, Stephen Massia, Bruce Kim, Gregory Raupp, Sensors and Actuators B, Vol. 102, Issue 1, pp. 67-72, September 2004
- [6]“Development of microelectrode arrays for artificial retinal implants using liquid crystal polymers”, S. W. Lee, J. M. Seo, S. Ha, E. T. Kim, H. Chung, and S. J. Kim, Invest Ophthalmol Vis Sci, Vol. 50, no. 12, pp. 5859-5866, December 2009.
- [7] M. S. Thesis, “A Study on a LCP-based Depth-type Neural Probe”, S. E. Lee, Department of electrical engineering and computer science, College of Engineering, Seoul National University, Seoul, Korea, 2010.
- [8]“A 16-site neural probe integrated with a waveguide for optical stimulation”, I.-J. Cho, H. W. Baac, and E. Yoon, in Proc. MEMS 2010 Conference, Hong Kong, China, Jan. 24-28, 2010, pp. 995-998.
- [9] Optical Absorption of Untreated and Laser-irradiated Tissues, D. K. SARDAR, B. M. ZAPATA, C. H. HOWARD, Lasers in Medical Science 1993, 8:205-209
- [10] Polymer-Based Microelectrode Arrays, Scott Corbertt, Joe Ketterl, and Tim Johnson, Master, Res. Soc. Symp. Proc, Vol. 926
- [11] Novel Biomedical Implant Interconnects Utilizing Micromachined LCP, Robert Dean, Jenny Weller, Mike Bozack, Brian Farrell, Linas Jauniskis, Josept Ting, David Edell, Jamile Hetke, Proc. of SPIE Vol. 5515
- Accordingly, an object of the present invention is to provide a liquid crystal polymer (LCP)-based electro-optrode neural interface having integrated electrode and optrode and a method of manufacturing the same.
- According to embodiments of the present invention, design and fabrication techniques of electrodes for stimulating deep brain regions, including the combination of optical technology and electrical and electronic technology, enable electrode design in which an optical technique for recording a neural signal without an artifact signal and an electrode technique for electrically recording a neural signal are embodied on a single electrode. Further, the use of LCP (liquid crystal polymer) and a semiconductor process enables the formation of various kinds of electrode site designs and multifunctional electrodes including fluidic channel, etc., and also enables the development for a coupling method with an optical fiber to achieve an optical technique. Furthermore, an integrated electrode can be provided in such a manner that the optical fiber is surrounded with an adhesive sheet in a thermoplastic thin-film form. A variety of neural signal recording methods and stimulation methods can be applied depending on needs, and the neural signal can be more exactly recorded using electrical and optical recording methods. Moreover, continuous disease treatment is possible using electrical stimulation as in conventional electrodes and optical stimulation as in specific cases such as generation of gliosis. MER and stimulation electrode insertion can be completed using one electrode operation, and the operation time can be shortened, thus reducing burdens on patients and operators, and also the electrode position can be monitored in real time, making it possible to perform a more exact electrode insertion operation.
-
FIG. 1 is a perspective view illustrating an electro-optrode neural interface according to an embodiment of the present invention; -
FIG. 2 is a cross-sectional view taken along the line II-II ofFIG. 1 illustrating the electro-optrode neural interface; -
FIG. 3 is a perspective view illustrating the electrode layer configuration of the electro-optrode neural interface ofFIG. 1 ; -
FIGS. 4 a to 4 g are a flowchart illustrating a process of manufacturing the electro-optrode neural interface ofFIG. 1 ; -
FIG. 5 is a flowchart illustrating another process of manufacturing the electro-optrode neural interface ofFIG. 1 ; -
FIG. 6 is a perspective view illustrating the entire configuration of an electro-optrode neural interface according to another embodiment of the present invention; and -
FIG. 7 is a flowchart illustrating a process of manufacturing the electro-optrode neural interface ofFIG. 6 . - Hereinafter, a detailed description will be given of embodiments of the present invention with reference to the appended drawings.
-
FIG. 1 is a perspective view illustrating an electro-optrode neural interface according to an embodiment of the present invention,FIG. 2 is a cross-sectional view taken along the line II-II ofFIG. 1 illustrating the electro-optrode neural interface, andFIG. 3 is a perspective view illustrating the electrode layer configuration of the electro-optrode neural interface ofFIG. 1 . - As illustrated in
FIGS. 1 to 3 , the electro-optrodeneural interface 100 according to the embodiment of the present invention is connected to an implanted device (not shown), so that biosignals collected in vivo are transferred to the implanted device, and the implanted device executes signal processing, storage and analysis of the transferred biosignals and sends the obtained results to the outside. The electro-optrodeneural interface 100 includes anoptical fiber 10 which is extended so as to be insertable into the body and is positioned at a core thereof so as to form an optical electrode portion, anadhesive sheet 20 surrounding theoptical fiber 10, anLCP electrode layer 30 wound on theoptical fiber 10 by means of theadhesive sheet 20 and pre-manufactured using a semiconductor process, and astimulation electrode site 40 attached to theadhesive sheet 20 at a distal end of theLCP electrode layer 30. - The
LCP electrode layer 30 is made of thermoplastic low-temperature LCP or high-temperature LCP, and may form a multi-channel electrode using a semiconductor process or a MEMS process. When theLCP electrode layer 30 is formed with the multi-channel electrode, information about not only one place, but of various places in viva may be obtained from respective electrodes. - The
adhesive sheet 20 functions to adhere or fix theLCP electrode layer 30 to theoptical fiber 10, and includes a low-temperature LCP film or polyurethane having adhesiveness and biocompatibility. Theadhesive sheet 20 and theLCP electrode layer 30 are coupled to each other to form anLCP sample 50. In the case where theLCP electrode layer 30 is integrated with theadhesive sheet 20 using a semiconductor process, like theLCP sample 50, theLCP electrode layer 30 may be omitted, and thus the diameter of the electro-optrode neural interface may decrease. - The
optical fiber 10, which is a part of the optical electrode, may perform optical neural signal measurement or stimulation, and acts as a lens such as an endoscope upon operation so that the interface is inserted into the body while avoiding cerebral blood vessels. Accordingly, a special optical fiber which withstands a temperature of 280˜290° C., for example, an optical fiber made of polyimide, polyurethane, etc., is preferably used. The end of theoptical fiber 10 may have a hemispherical shape as illustrated inFIG. 1 , but may have a variety of shapes such as a conical shape, a flat surface, etc., depending on the cutting and processing type. - The
stimulation electrode site 40 is made of a metal, for example, Au or Pt, having a thickness of hundreds of nanometers through which an electrical stimulation waveform passes, and executes current/optical signal recording and electrical stimulation. Thestimulation electrode site 40 has afluidic channel 42 configured to inject a drug into the region in which the electrode is inserted. - The electro-optrode neural interface according to the present invention is formed by combining a micro electrode for recording a neural signal and a stimulation electrode, has high long-term stability, and is configured such that a neural electrode is formed using the
LCP film 50 comprising the LCP electrode layer and theadhesive sheet 20 integrated with each other, and theoptical fiber 10 is surrounded therewith. - The neural electrode using the
LCP film 50 comprising the LCP electrode layer and theadhesive sheet 20 integrated with each other plays a role in recording the neural signal and performing multiple functions including electrical stimulation, drug delivery, etc., and theoptical fiber 10 is responsible for recording the neural signal and for the function of the stimulation electrode. - As the neural signal recording electrode and the stimulation electrode are integrated with each other, the electrode insertion operation need only be completed once, thus shortening the operation time.
- The electro-optrode neural interface according to the present invention is able to use the optical fiber as an endoscope and thus whether the cerebral blood vessel is present or not may be observed with the naked eye in real time using the overall reflective property of the optical fiber. Also, when the integration of peripheral circuits is accomplished, the electro-optrode neural interface according to the present invention enables the direction of electrode entry to be changed variously like in the case of currently used endoscopes, and may thus be developed into a future electrode that is inserted up to the stimulus position while avoiding causing damage to cerebral blood vessels, in lieu of the linear electrode insertion which is currently mainly performed. Ultimately, difficulties in monitoring the position of the electrode are solved.
- Although gliosis is not entirely avoided when using external materials, the stimulation electrode of the invention is an optical electrode using an optical technique and thus stimulation of tissue using the optical electrode, namely, optical stimulation, is possible even when gliosis surrounds the electrode, thereby solving problems of gliosis caused by the immune response, etc.
- The method of manufacturing the electro-optrode neural interface according to the present invention is described below with reference to
FIG. 4 . - As illustrated in
FIG. 4 a, anLCP electrode layer 30, which is pre-manufactured in a long tape form, anadhesive sheet 20, and anoptical fiber 10 that withstands a temperature of about 300° C. are prepared. The pre-manufacturedLCP electrode layer 30 may be integrated with theadhesive sheet 20 using a semiconductor process, and the LCP electrode layer and the adhesive sheet, which are integrated with each other, refer to anLCP sample 50. For the sake of description, the manufacturing method using theLCP sample 50 is described. - Subsequently, as illustrated in
FIG. 4 b, theLCP sample 50 is densely wound on theoptical fiber 10, and theoptical fiber 10 is mechanically held to a cylindricaloptical fiber fixer 60. As such, theoptical fiber 10 is held by being pulled at a predetermined tension so that pressure applied to theLCP sample 50 is maintained constant. - Subsequently, as illustrated in
FIG. 4 c (the right is a cross-sectional view in the arrow direction), theprepared LCP sample 50 is placed in ametal mold 70 and heated while being rotated. The heating temperature is set so that the temperature applied to theLCP sample 50 is about 275˜280° C., and theLCP sample 50 is rotated in non-contact type so as not to come into direct contact with themetal mold 70. This is intended to prevent thermal deformation of theoptical fiber 10, which is unnecessary and undesirable. In the drawing, thereference numeral 72 is an alignment pin of theLCP 50 and themetal mold 70. - As an alternative heating process, as illustrated in
FIG. 4 d (the right is a cross-sectional view in the arrow direction), theprepared LCP sample 50 is placed in ametal mold 70 and heated. Arepulsive layer 80 made of Teflon is disposed between theoptical fiber 10 and themetal mold 70 in order to prevent the electrode layer from being melted and attached to themetal mold 70 during the heating. The heating temperature is set so that the temperature applied to theLCP sample 50 is about 275˜280° C. This case is performed when heat resistance of theoptical fiber 10 is very high, and is advantageous because the process time is short and the roughness of the entire electrode is low. - As another alternative heating process, a mixed heating process including the non-contact type and the contact type may be performed. As illustrated in
FIG. 4 e (the right is a cross-sectional view in the arrow direction), the mixed heating process is performed by disposing arepulsive layer 80 between theLCP sample 50 and themetal mold 70 and periodically tapping theLCP sample 50 by themetal mold 70 at a regular temporal interval, that is, repeatedly applying predetermined pressure. Furthermore, theLCP sample 50 is heated while being rotated in themetal mold 70. The heating temperature is set so that the temperature applied to theLCP sample 50 is about 275˜280° C. As themetal mold 70 comes into periodic contact with theLCP sample 50, the thermal deformation of theoptical fiber 10, which is unnecessary and undesirable, is prevented. - The above-mentioned heating process enables the LCP electrode layer to be melted by means of heat and pressure so as to attach the adhesive sheet and the optical fiber to each other. This refers to lamination. While the LCP electrode layer is melted under predetermined temperature and pressure conditions, it is coupled to the optical fiber.
- After completion of the heating process, as illustrated in
FIG. 4 f, the tip of theoptical fiber 10, which is unnecessarily long, is cut using a fiber cutter, thus manufacturing the electro-optrodeneural interface 100 according to the present invention. - Finally, as illustrated in
FIG. 4 g, astimulation electrode site 40 is attached to the manufactured electro-optrodeneural interface 100. In the electro-optrodeneural interface 100, the portion where theoptical fiber 10 is exposed is responsible for recording the neural signal using the optical signal, checking for the presence of the cerebral blood vessel upon an electrode insertion operation to execute optical simulation, and measuring the reflectance of the optical signal during the insertion, so that the position of the inserted electro-optrode neural interface may be monitored in real time. Even when gliosis occurs, deep brain stimulation effects may be induced via optical stimulation. - The
stimulation electrode site 40 wherein the electrical signal is recorded and the electrical stimulation is executed may have multiple channels depending on the type of design, and impedance or charge injection limit may become diversified depending on the material for the site. -
FIG. 5 illustrates another process of manufacturing the electro-optrode neural interface. - As illustrated in
FIG. 5 , aprepared LCP sample 50 is disposed at upper and lower positions of anoptical fiber 10, and arepulsive layer 80 is disposed between theoptical fiber 10 and ametal mold 70, and the resulting sample is placed in themetal mold 70. - Subsequently, the
metal mold 70 is heated. Accordingly, theLCP sample 50 at the upper and lower positions of theoptical fiber 10 is fused and transformed so as to surround theoptical fiber 10. During the heating, the transformation of theLCP sample 50, that is, low-temperature LCP material is induced at 270° C. for a predetermined period of time, after which heating is carried out under pressure so that the heating temperature is about 275˜280° C. - Subsequently, a necessary portion is cut using laser processing, and a heating process is performed, thereby forming a final electro-optrode neural interface.
-
FIG. 6 is a perspective view illustrating an electro-optrode neural interface according to another embodiment of the present invention. As illustrated inFIG. 6 , the electro-optrodeneural interface 200 according to another embodiment of the present invention includes asubstrate portion 210 made of high-temperature or low-temperature LCP,electrode portions 220 formed on the upper side of thesubstrate portion 210 and spaced apart from each other to collect biosignals and to transfer the collected biosignals, and anoptrode portion 240 formed on the upper side of thesubstrate portion 210 between theelectrode portions 220 to form an optical electrode portion. - The electro-
optrode interface 200 according to the present invention is connected to an implanted device (not shown), so that biosignals collected in vivo are transferred to the implanted device, and the implanted device performs signal processing, storage and analysis of the transferred biosignals and sends the obtained results to the outside. - The
electrode portions 220 are formed by patterning a metal such as Au on thesubstrate portion 210. Theelectrode portions 220 may be formed with a multi-channel electrode, or may be formed using a MEMS process. - The
optrode portion 240 is formed by patterning a patternable transparent material, that is, a photopolymer such as SU-8, and may be formed to be a desired size, enables light to pass therethrough, and may be formed using a MEMS process. - The
substrate portion 210 functions to protect theelectrode portions 220 and theoptrode portion 240, and is made of LCP, especially low-temperature LCP. - With reference to
FIG. 7 , the electro-optrodeneural interface 200 further includes a cover portion 260 layered on thesubstrate portion 210 so as to protect theelectrode portions 220 and theoptrode portion 240. - The cover portion 260 is formed using hot pressing on the
substrate portion 210, and is made of high-temperature or low-temperature LCP, especially low-temperature LCP, as in thesubstrate portion 210. In the case of high-temperature LCP, an adhesive layer of low-temperature LCP may be additionally required between thesubstrate portion 210 and the cover portion 260. - The electro-optrode neural interface according to another embodiment of the present invention is manufactured as illustrated in
FIG. 7 . - The upper side of a
substrate portion 210 having an approximate rectangular shape is subjected to Au patterning, thus formingelectrode portions 220 extended in a longitudinal direction of thesubstrate portion 210 and spaced apart from each other. Subsequently, the space between theelectrode portions 220 is patterned with a photopolymer such as SU-8 so as not to overlap with theelectrode portions 220 formed on thesubstrate portion 210, thus forming anoptrode portion 240. - A cover portion 260 made of LCP is placed on the
substrate portion 210 having theelectrode portions 220 and theoptrode portion 240 formed thereon and then laminated. As such, the cover portion 260 is laminated so as to provide 242 and 246 which expose parts of theexposure portions electrode portions 220 and theoptrode portion 240. Theexposure portion 242 is formed close to the insertion direction of the body, through which biosignals are collected. Theexposure portion 246, which is located opposite to theexposure portion 242, functions to transfer the biosignals collected by theexposure portion 242 to an implanted device (not shown). - Subsequently, a part of the
substrate portion 210 other than theelectrode portions 220 and theoptrode portion 240 formed on thesubstrate portion 210 laminated with the cover portion 260 is cut using a laser, thus manufacturing the electro-optrodeneural interface 200 as illustrated inFIG. 6 . - To connect a feed-through 280 to the manufactured electro-optrode
neural interface 200, alignment holes 262 are formed in the interface, and the feed-through 280 is connected using the alignment holes 262. - The feed-through 280 includes an
electrical cable 282 so that theelectrode portions 220 are connected to an electrical circuit element of the implanted device, and theoptrode portion 240 is connected to a measurement element of the implanted device which measures the generation of an optical signal. The feed-through is coated with an insulating material so as to prevent it from being exposed to the outside. - Although the preferred embodiments of the present invention regarding the LCP-based electro-optrode neural interface and the method of manufacturing the same according to the present invention have been disclosed for illustrative purposes, the present invention is not limited to such embodiments, and those skilled in the art will appreciate that various modifications, additions and substitutions are possible, without departing from the scope and spirit of the invention as disclosed in the accompanying claims.
Claims (14)
1. A liquid crystal polymer (LCP)-based electro-optrode neural interface, comprising:
an optical fiber, which is extended to be insertable into a body and is positioned at a core thereof so as to form an optical electrode portion; and
an LCP sample surrounding the optical fiber,
wherein the LCP sample includes an adhesive sheet and an LCP electrode layer surrounding the adhesive sheet and coupled to the adhesive sheet.
2. The electro-optrode neural interface of claim 1 , wherein the optical fiber comprises a material which withstands a temperature of 280˜290° C.
3. The electro-optrode neural interface of claim 1 , wherein the LCP electrode layer includes an electrode of an electrical stimulation site made of a multi-channel metal layer using a semiconductor process or a MEMS process,
the electro-optrode neural interface includes an interface made of the optical fiber to perform optical neural signal recording and stimulation, and
the electrical stimulation site includes a fluidic channel configured to inject a drug into a region where the electrode is inserted, in addition to current/optical signal recording and stimulation.
4. A method of manufacturing an LCP-based electro-optrode neural interface, comprising:
winding an LCP sample on an optical fiber;
heating the LCP sample wound on the optical fiber using a metal mold so that the LCP sample is laminated on the optical fiber; and
cutting an unnecessary tip of the optical fiber laminated with the LCP sample, thus forming the electro-optrode neural interface.
5. The method of claim 4 , wherein the heating comprises placing the LCP sample wound on the optical fiber in the metal mold and heating it while being rotated, and the metal mold and the LCP sample do not come into direct contact with each other.
6. The method of claim 4 , wherein the heating is performed so that a temperature applied to the LCP sample is 275˜285° C.
7. The method of claim 4 , wherein the heating comprises placing the LCP sample wound on the optical fiber in the metal mold and heating it.
8. The method of claim 4 , wherein the heating comprises placing the LCP sample wound on the optical fiber in the metal mold and heating it while being rotated, and is performed in such a manner that the LCP sample is periodically tapped by the metal mold at a predetermined temporal interval.
9. The method of claim 4 , wherein the heating comprises disposing the LCP sample at upper and lower positions of the optical fiber, placing the LCP sample and the optical fiber in the metal mold, and heating them.
10. An LCP-based electro-optrode neural interface, comprising:
a substrate portion made of LCP;
electrode portions formed on an upper side of the substrate portion to collect biosignals and to transfer the collected biosignals;
an optrode portion formed on the upper side of the substrate portion so as not to overlap with the electrode portions in order to form an optical electrode portion; and
a cover portion made of LCP, protecting the electrode portions and the optrode portion, and laminated on the substrate portion using hot pressing so as to expose a part of the optrode portion.
11. The electro-optrode neural interface of claim 10 , wherein the electrode portions are formed by patterning a metal material on the substrate portion.
12. The electro-optrode neural interface of claim 10 , wherein the optrode portion is formed by patterning a photopolymer on the substrate portion.
13. A method of manufacturing an LCP-based electro-optrode neural interface, comprising:
forming electrode portions on an upper side of a substrate portion made of LCP;
forming an optrode portion on the upper side of the substrate portion so as not to overlap with the electrode portions;
laminating a cover portion made of LCP on the substrate portion so as to expose a part of the optrode portion; and
cutting a region of the substrate portion other than the electrode portions and the optrode portion of the substrate portion laminated with the cover portion, thus manufacturing the electro-optrode neural interface.
14. The method of claim 13 , further comprising:
forming an alignment hole in the electro-optrode neural interface; and
connecting a feed-through to the electro-optrode neural interface using the alignment hole.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20100103026 | 2010-10-21 | ||
| KR1020100103026 | 2010-10-21 | ||
| KR1020110090040A KR101304338B1 (en) | 2010-10-21 | 2011-09-06 | LCP-based electro-optrode neural interface and Method for fabricating the same |
| KR1020110090040 | 2011-09-06 | ||
| PCT/KR2011/007778 WO2012053815A2 (en) | 2010-10-21 | 2011-10-19 | Liquid crystal polymer-based electro-optrode neural interface, and method for producing same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US20130237906A1 true US20130237906A1 (en) | 2013-09-12 |
Family
ID=46873771
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US13/880,421 Abandoned US20130237906A1 (en) | 2010-10-21 | 2011-10-19 | Liquid crystal polymer-based electro-optrode neural interface, and method for producing same |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20130237906A1 (en) |
| EP (1) | EP2630986B1 (en) |
| JP (1) | JP2013543743A (en) |
| KR (1) | KR101304338B1 (en) |
| CN (1) | CN103167892B (en) |
| AU (1) | AU2011318749A1 (en) |
| SG (1) | SG189526A1 (en) |
| WO (1) | WO2012053815A2 (en) |
Cited By (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150018901A1 (en) * | 2013-07-11 | 2015-01-15 | Board Of Trustees Of Michigan State University | Neural prosthetic device and method of making same |
| WO2015094076A1 (en) | 2013-12-20 | 2015-06-25 | Neuronano Ab | Medical device comprising an electrode and a light source |
| US20160175606A1 (en) * | 2014-12-17 | 2016-06-23 | Gwangju Institute Of Science And Technology | Optical stimulator using electrochromism |
| WO2017015395A1 (en) * | 2015-07-21 | 2017-01-26 | The Board Of Trustees Of The Leland Stanford Junior University | Carbon fiber optrodes for magnetic resonance imaging compatible optogenetics |
| US20170232250A1 (en) * | 2014-08-08 | 2017-08-17 | Seoul National University R&Db Foundation | Liquid crystal polymer-based electrode array and package for neural implant, and manufacturing method therefor |
| US10195429B1 (en) | 2017-08-02 | 2019-02-05 | Lungpacer Medical Inc. | Systems and methods for intravascular catheter positioning and/or nerve stimulation |
| US10293164B2 (en) | 2017-05-26 | 2019-05-21 | Lungpacer Medical Inc. | Apparatus and methods for assisted breathing by transvascular nerve stimulation |
| WO2019109002A1 (en) * | 2017-11-30 | 2019-06-06 | Case Western Reserve University | System for long-term modulation of peripheral nerve activity with light |
| US10391314B2 (en) | 2014-01-21 | 2019-08-27 | Lungpacer Medical Inc. | Systems and related methods for optimization of multi-electrode nerve pacing |
| US10406367B2 (en) | 2012-06-21 | 2019-09-10 | Lungpacer Medical Inc. | Transvascular diaphragm pacing system and methods of use |
| US10512772B2 (en) | 2012-03-05 | 2019-12-24 | Lungpacer Medical Inc. | Transvascular nerve stimulation apparatus and methods |
| US10561843B2 (en) | 2007-01-29 | 2020-02-18 | Lungpacer Medical, Inc. | Transvascular nerve stimulation apparatus and methods |
| US10940308B2 (en) | 2017-08-04 | 2021-03-09 | Lungpacer Medical Inc. | Systems and methods for trans-esophageal sympathetic ganglion recruitment |
| US10987511B2 (en) | 2018-11-08 | 2021-04-27 | Lungpacer Medical Inc. | Stimulation systems and related user interfaces |
| US20220118258A1 (en) * | 2017-05-26 | 2022-04-21 | Newton Howard | Brain monitoring and stimulation devices and methods |
| US11357979B2 (en) | 2019-05-16 | 2022-06-14 | Lungpacer Medical Inc. | Systems and methods for sensing and stimulation |
| US11504038B2 (en) | 2016-02-12 | 2022-11-22 | Newton Howard | Early detection of neurodegenerative disease |
| CN116164859A (en) * | 2023-02-17 | 2023-05-26 | 之江实验室 | A high-sensitivity temperature sensor based on double-helix micro-nano fiber structure |
| US11707619B2 (en) | 2013-11-22 | 2023-07-25 | Lungpacer Medical Inc. | Apparatus and methods for assisted breathing by transvascular nerve stimulation |
| US11771900B2 (en) | 2019-06-12 | 2023-10-03 | Lungpacer Medical Inc. | Circuitry for medical stimulation systems |
| US20230408404A1 (en) * | 2020-04-06 | 2023-12-21 | Joyson Safety Systems Acquisition Llc | Systems and methods of ambient gas sensing in a vehicle |
| US11883658B2 (en) | 2017-06-30 | 2024-01-30 | Lungpacer Medical Inc. | Devices and methods for prevention, moderation, and/or treatment of cognitive injury |
| US11957897B2 (en) | 2016-04-22 | 2024-04-16 | Newton Howard | Biological co-processor (BCP) |
| US11998739B2 (en) | 2017-07-12 | 2024-06-04 | Cochlear Limited | Monolithic component for an implantable medical device |
| US12029903B2 (en) | 2017-12-11 | 2024-07-09 | Lungpacer Medical Inc. | Systems and methods for strengthening a respiratory muscle |
| US12379130B2 (en) | 2021-04-06 | 2025-08-05 | Joyson Safety Systems Acquisition Llc | Gas monitoring device and system |
| US12428543B2 (en) | 2021-05-18 | 2025-09-30 | Ticona Llc | Connected medical device containing a liquid crystalline polymer composition having a low dielectric constant |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE537219C2 (en) * | 2013-03-15 | 2015-03-03 | Karin Wårdell | Combination probe for location, registration and operative stimulation of a target tissue |
| US9986914B2 (en) * | 2013-05-24 | 2018-06-05 | University Of Houston System | Method of fabricating a probe |
| CN103462600B (en) * | 2013-09-04 | 2015-04-15 | 中国科学院深圳先进技术研究院 | Photoelectrode component and in-vivo photoelectrode imaging system |
| KR101537932B1 (en) * | 2013-10-01 | 2015-07-20 | 서울대학교산학협력단 | Polymer-based hybrid neural electrode array with fluidic channel and manufacturing method thereof |
| KR101518245B1 (en) * | 2014-06-17 | 2015-05-11 | 한국과학기술연구원 | Neural Probe Array having a channel for injecting medical substances |
| DE102014014942A1 (en) * | 2014-10-07 | 2016-04-07 | Neuroloop GmbH | Implantable arrangement |
| JPWO2016185525A1 (en) * | 2015-05-15 | 2018-03-01 | 合同会社プロモベオ | Brain electrode |
| FR3036623B1 (en) * | 2015-05-28 | 2017-05-19 | Commissariat Energie Atomique | DEVICE FOR DEEP ELECTRICAL AND OPTICAL STIMULATION OF THE BRAIN |
| KR101731231B1 (en) * | 2015-07-31 | 2017-04-28 | 재단법인 오송첨단의료산업진흥재단 | Implantable hybrid lead and a method of manufacturing the same |
| WO2017204610A1 (en) * | 2016-05-27 | 2017-11-30 | 주식회사 토닥 | Bio-implantable device and method for manufacturing same |
| CN106291813A (en) * | 2016-09-07 | 2017-01-04 | 中国科学院半导体研究所 | Many measuring points transparent optical electrode based on optical fiber |
| JP7329442B2 (en) * | 2017-01-19 | 2023-08-18 | セント・ジュード・メディカル,カーディオロジー・ディヴィジョン,インコーポレイテッド | Sheath visualization |
| CN109199377A (en) * | 2017-07-03 | 2019-01-15 | 诺尔医疗(深圳)有限公司 | Intracranical deep electrode and medical instrument |
| WO2019020985A1 (en) | 2017-07-28 | 2019-01-31 | Galvani Bioelectronics Limited | Electrode devices for neurostimulation |
| CN107638175B (en) * | 2017-08-24 | 2020-12-01 | 国家纳米科学中心 | A flexible electrode array-fiber composite nerve electrode and preparation method thereof |
| CN109431464B (en) * | 2018-10-25 | 2021-05-18 | 惠良图 | Multifunctional anesthesia depth monitoring device for anesthesia department |
| KR102344758B1 (en) * | 2019-12-10 | 2021-12-30 | 사회복지법인 삼성생명공익재단 | Implantable medical device capable of releasing anti-inflammatory agents |
| WO2021141163A1 (en) * | 2020-01-09 | 2021-07-15 | 서울시립대학교 산학협력단 | Deep brain stimulation transparent electrode array and neural signal detection method using same |
| CN111437514A (en) * | 2020-03-31 | 2020-07-24 | 北京航空航天大学 | Optical fiber probe for simultaneously realizing deep brain light stimulation and electroencephalogram detection and preparation method thereof |
| CN112121306B (en) * | 2020-06-05 | 2024-04-19 | 未来穿戴技术有限公司 | Electrode plate manufacturing method, electrode plate and neck massager |
| CN112099160B (en) * | 2020-08-14 | 2021-06-22 | 中国科学院上海微系统与信息技术研究所 | Back-end connection structure of an implantable neural photoelectrode and preparation method thereof |
| CN115227419A (en) * | 2022-08-24 | 2022-10-25 | 苏州密尔光子科技有限公司 | A kind of laser swing cleaning equipment and method |
| CN116035588B (en) * | 2023-01-13 | 2023-11-07 | 光子集成(温州)创新研究院 | Neural interface and heart monitor based on neural interface |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090156918A1 (en) * | 2007-12-12 | 2009-06-18 | Davis Timothy J | Implantable optical sensor and method for use |
| US7666284B2 (en) * | 2000-05-12 | 2010-02-23 | Abbott Diabetes Care Inc. | Electrodes with multilayer membranes and methods of using and making the electrodes |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1993023495A1 (en) * | 1992-05-20 | 1993-11-25 | Neste Oy | Electrically conducting liquid-crystal polymers and process for preparation thereof |
| GB2277323A (en) * | 1993-04-06 | 1994-10-26 | Secr Defence | Liquid crystal polymers |
| GB2304723B (en) * | 1995-09-05 | 2000-04-05 | Peter Jonathan Samuel Foot | Liquid-crystalline conducting polymers |
| JP4118062B2 (en) * | 2002-02-07 | 2008-07-16 | 株式会社ニデック | Intraocular implant device |
| US7480433B2 (en) * | 2002-02-19 | 2009-01-20 | Tufts University | Electro-optical stimulation/measurement |
| US6644552B1 (en) | 2002-07-09 | 2003-11-11 | John Herslow | Composite card |
| US7316789B2 (en) * | 2004-11-02 | 2008-01-08 | International Business Machines Corporation | Conducting liquid crystal polymer nature comprising carbon nanotubes, use thereof and method of fabrication |
| JP2008520280A (en) * | 2004-11-15 | 2008-06-19 | デチャームス,クリストファー | Application of nerve tissue stimulation using light |
| US9238150B2 (en) * | 2005-07-22 | 2016-01-19 | The Board Of Trustees Of The Leland Stanford Junior University | Optical tissue interface method and apparatus for stimulating cells |
| US20090093403A1 (en) * | 2007-03-01 | 2009-04-09 | Feng Zhang | Systems, methods and compositions for optical stimulation of target cells |
| US20080027347A1 (en) * | 2006-06-23 | 2008-01-31 | Neuro Vista Corporation, A Delaware Corporation | Minimally Invasive Monitoring Methods |
| US8160696B2 (en) * | 2008-10-03 | 2012-04-17 | Lockheed Martin Corporation | Nerve stimulator and method using simultaneous electrical and optical signals |
| JP5216230B2 (en) * | 2007-03-29 | 2013-06-19 | Jx日鉱日石エネルギー株式会社 | Conductive resin composition |
| US10434327B2 (en) * | 2007-10-31 | 2019-10-08 | The Board Of Trustees Of The Leland Stanford Junior University | Implantable optical stimulators |
| KR101028949B1 (en) | 2008-07-23 | 2011-04-12 | 재단법인서울대학교산학협력재단 | Neuronal user interface devices, methods and devices for measuring brain activity |
| KR20100056872A (en) | 2008-11-20 | 2010-05-28 | 김현피 | Valve apparatus |
| KR101045866B1 (en) | 2008-11-20 | 2011-07-01 | 서울대학교산학협력단 | Neural signal measuring apparatus and method using optical fiber |
| KR101051025B1 (en) * | 2008-12-23 | 2011-07-26 | 한국과학기술연구원 | Brain stimulation and measurement apparatus and method of manufacturing the same |
| KR101088806B1 (en) | 2009-01-07 | 2011-12-01 | 주식회사 뉴로바이오시스 | Microelectrode array package using liquid crystal polymer and manufacturing method thereof |
-
2011
- 2011-09-06 KR KR1020110090040A patent/KR101304338B1/en active Active
- 2011-10-19 JP JP2013534816A patent/JP2013543743A/en active Pending
- 2011-10-19 CN CN201180050661.XA patent/CN103167892B/en not_active Expired - Fee Related
- 2011-10-19 AU AU2011318749A patent/AU2011318749A1/en not_active Abandoned
- 2011-10-19 US US13/880,421 patent/US20130237906A1/en not_active Abandoned
- 2011-10-19 SG SG2013031596A patent/SG189526A1/en unknown
- 2011-10-19 EP EP11834615.4A patent/EP2630986B1/en not_active Not-in-force
- 2011-10-19 WO PCT/KR2011/007778 patent/WO2012053815A2/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7666284B2 (en) * | 2000-05-12 | 2010-02-23 | Abbott Diabetes Care Inc. | Electrodes with multilayer membranes and methods of using and making the electrodes |
| US20090156918A1 (en) * | 2007-12-12 | 2009-06-18 | Davis Timothy J | Implantable optical sensor and method for use |
Cited By (53)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10864374B2 (en) | 2007-01-29 | 2020-12-15 | Lungpacer Medical Inc. | Transvascular nerve stimulation apparatus and methods |
| US10792499B2 (en) | 2007-01-29 | 2020-10-06 | Lungpacer Medical Inc. | Transvascular nerve stimulation apparatus and methods |
| US12268877B2 (en) | 2007-01-29 | 2025-04-08 | Lungpacer Medical Inc. | Transvascular nerve stimulation apparatus and methods |
| US10765867B2 (en) | 2007-01-29 | 2020-09-08 | Lungpacer Medical Inc. | Transvascular nerve stimulation apparatus and methods |
| US10561843B2 (en) | 2007-01-29 | 2020-02-18 | Lungpacer Medical, Inc. | Transvascular nerve stimulation apparatus and methods |
| US11027130B2 (en) | 2007-01-29 | 2021-06-08 | Lungpacer Medical Inc. | Transvascular nerve stimulation apparatus and methods |
| US10512772B2 (en) | 2012-03-05 | 2019-12-24 | Lungpacer Medical Inc. | Transvascular nerve stimulation apparatus and methods |
| US11369787B2 (en) | 2012-03-05 | 2022-06-28 | Lungpacer Medical Inc. | Transvascular nerve stimulation apparatus and methods |
| US11357985B2 (en) | 2012-06-21 | 2022-06-14 | Lungpacer Medical Inc. | Transvascular diaphragm pacing systems and methods of use |
| US10406367B2 (en) | 2012-06-21 | 2019-09-10 | Lungpacer Medical Inc. | Transvascular diaphragm pacing system and methods of use |
| US10561844B2 (en) | 2012-06-21 | 2020-02-18 | Lungpacer Medical Inc. | Diaphragm pacing systems and methods of use |
| US10589097B2 (en) | 2012-06-21 | 2020-03-17 | Lungpacer Medical Inc. | Transvascular diaphragm pacing systems and methods of use |
| US20150018901A1 (en) * | 2013-07-11 | 2015-01-15 | Board Of Trustees Of Michigan State University | Neural prosthetic device and method of making same |
| US10004917B2 (en) * | 2013-07-11 | 2018-06-26 | Board Of Trustees Of Michigan State University | Neural prosthetic device and method of making same |
| US11707619B2 (en) | 2013-11-22 | 2023-07-25 | Lungpacer Medical Inc. | Apparatus and methods for assisted breathing by transvascular nerve stimulation |
| US12239838B2 (en) | 2013-11-22 | 2025-03-04 | Lungpacer Medical Inc. | Apparatus and methods for assisted breathing by transvascular nerve stimulation |
| US11583233B2 (en) | 2013-12-20 | 2023-02-21 | Neuronano Ab | Medical device comprising an electrode and a light source |
| WO2015094076A1 (en) | 2013-12-20 | 2015-06-25 | Neuronano Ab | Medical device comprising an electrode and a light source |
| US11311730B2 (en) | 2014-01-21 | 2022-04-26 | Lungpacer Medical Inc. | Systems and related methods for optimization of multi-electrode nerve pacing |
| US10391314B2 (en) | 2014-01-21 | 2019-08-27 | Lungpacer Medical Inc. | Systems and related methods for optimization of multi-electrode nerve pacing |
| US12172020B2 (en) | 2014-01-21 | 2024-12-24 | Lungpacer Medical Inc. | Systems and related methods for optimization of multi-electrode nerve pacing |
| US10500393B2 (en) * | 2014-08-08 | 2019-12-10 | Seoul National University R&Db Foundation | Liquid crystal polymer-based electrode array and package for neural implant, and manufacturing method therefor |
| US20170232250A1 (en) * | 2014-08-08 | 2017-08-17 | Seoul National University R&Db Foundation | Liquid crystal polymer-based electrode array and package for neural implant, and manufacturing method therefor |
| US20160175606A1 (en) * | 2014-12-17 | 2016-06-23 | Gwangju Institute Of Science And Technology | Optical stimulator using electrochromism |
| US11684284B2 (en) | 2015-07-21 | 2023-06-27 | The Board Of Trustees Of The Leland Stanford Junior University | Carbon fiber optrodes for magnetic resonance imaging compatible optogenetics |
| WO2017015395A1 (en) * | 2015-07-21 | 2017-01-26 | The Board Of Trustees Of The Leland Stanford Junior University | Carbon fiber optrodes for magnetic resonance imaging compatible optogenetics |
| US11504038B2 (en) | 2016-02-12 | 2022-11-22 | Newton Howard | Early detection of neurodegenerative disease |
| US11957897B2 (en) | 2016-04-22 | 2024-04-16 | Newton Howard | Biological co-processor (BCP) |
| US20220118258A1 (en) * | 2017-05-26 | 2022-04-21 | Newton Howard | Brain monitoring and stimulation devices and methods |
| US10293164B2 (en) | 2017-05-26 | 2019-05-21 | Lungpacer Medical Inc. | Apparatus and methods for assisted breathing by transvascular nerve stimulation |
| US12029901B2 (en) | 2017-06-30 | 2024-07-09 | Lungpacer Medical Inc. | Devices and methods for prevention, moderation, and/or treatment of cognitive injury |
| US11883658B2 (en) | 2017-06-30 | 2024-01-30 | Lungpacer Medical Inc. | Devices and methods for prevention, moderation, and/or treatment of cognitive injury |
| US11998739B2 (en) | 2017-07-12 | 2024-06-04 | Cochlear Limited | Monolithic component for an implantable medical device |
| US10195429B1 (en) | 2017-08-02 | 2019-02-05 | Lungpacer Medical Inc. | Systems and methods for intravascular catheter positioning and/or nerve stimulation |
| US10926087B2 (en) | 2017-08-02 | 2021-02-23 | Lungpacer Medical Inc. | Systems and methods for intravascular catheter positioning and/or nerve stimulation |
| US11090489B2 (en) | 2017-08-02 | 2021-08-17 | Lungpacer Medical, Inc. | Systems and methods for intravascular catheter positioning and/or nerve stimulation |
| US12029902B2 (en) | 2017-08-02 | 2024-07-09 | Lungpacer Medical Inc. | Intravascular catheter methods |
| US11944810B2 (en) | 2017-08-04 | 2024-04-02 | Lungpacer Medical Inc. | Systems and methods for trans-esophageal sympathetic ganglion recruitment |
| US10940308B2 (en) | 2017-08-04 | 2021-03-09 | Lungpacer Medical Inc. | Systems and methods for trans-esophageal sympathetic ganglion recruitment |
| WO2019109002A1 (en) * | 2017-11-30 | 2019-06-06 | Case Western Reserve University | System for long-term modulation of peripheral nerve activity with light |
| EP4272811A3 (en) * | 2017-11-30 | 2024-02-07 | Case Western Reserve University | System for long-term modulation of peripheral nerve activity with light |
| US12029903B2 (en) | 2017-12-11 | 2024-07-09 | Lungpacer Medical Inc. | Systems and methods for strengthening a respiratory muscle |
| US10987511B2 (en) | 2018-11-08 | 2021-04-27 | Lungpacer Medical Inc. | Stimulation systems and related user interfaces |
| US11890462B2 (en) | 2018-11-08 | 2024-02-06 | Lungpacer Medical Inc. | Stimulation systems and related user interfaces |
| US11717673B2 (en) | 2018-11-08 | 2023-08-08 | Lungpacer Medical Inc. | Stimulation systems and related user interfaces |
| US11357979B2 (en) | 2019-05-16 | 2022-06-14 | Lungpacer Medical Inc. | Systems and methods for sensing and stimulation |
| US12403312B2 (en) | 2019-06-12 | 2025-09-02 | Lungpacer Medical Inc. | Circuitry for medical stimulation systems |
| US11771900B2 (en) | 2019-06-12 | 2023-10-03 | Lungpacer Medical Inc. | Circuitry for medical stimulation systems |
| US12313536B2 (en) * | 2020-04-06 | 2025-05-27 | Joyson Safety Systems Acquisition Llc | Systems and methods of ambient gas sensing in a vehicle |
| US20230408404A1 (en) * | 2020-04-06 | 2023-12-21 | Joyson Safety Systems Acquisition Llc | Systems and methods of ambient gas sensing in a vehicle |
| US12379130B2 (en) | 2021-04-06 | 2025-08-05 | Joyson Safety Systems Acquisition Llc | Gas monitoring device and system |
| US12428543B2 (en) | 2021-05-18 | 2025-09-30 | Ticona Llc | Connected medical device containing a liquid crystalline polymer composition having a low dielectric constant |
| CN116164859A (en) * | 2023-02-17 | 2023-05-26 | 之江实验室 | A high-sensitivity temperature sensor based on double-helix micro-nano fiber structure |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2013543743A (en) | 2013-12-09 |
| SG189526A1 (en) | 2013-05-31 |
| AU2011318749A1 (en) | 2013-06-06 |
| KR101304338B1 (en) | 2013-09-11 |
| WO2012053815A3 (en) | 2012-07-26 |
| KR20120088501A (en) | 2012-08-08 |
| CN103167892B (en) | 2015-04-01 |
| WO2012053815A2 (en) | 2012-04-26 |
| EP2630986B1 (en) | 2014-12-10 |
| CN103167892A (en) | 2013-06-19 |
| EP2630986A4 (en) | 2014-04-16 |
| EP2630986A2 (en) | 2013-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2630986B1 (en) | Liquid crystal polymer-based electro-optrode neural interface, and method for producing same | |
| US20230045240A1 (en) | Deep brain stimulation transparent electrode array and neural signal detection method using same | |
| Choi et al. | Stretchable, dynamic covalent polymers for soft, long-lived bioresorbable electronic stimulators designed to facilitate neuromuscular regeneration | |
| Lee et al. | Soft high-resolution neural interfacing probes: Materials and design approaches | |
| KR102128092B1 (en) | Deep brain stimulation transparent electrodes array and neural signal detection method using the same | |
| Lu et al. | Polymer fiber probes enable optical control of spinal cord and muscle function in vivo | |
| Sung et al. | Flexible wireless powered drug delivery system for targeted administration on cerebral cortex | |
| Lee et al. | A flexible depth probe using liquid crystal polymer | |
| ES2719955T3 (en) | Systems for evaluation and modification of traffic and neurological receptors | |
| Yan et al. | Ultraflexible and stretchable intrafascicular peripheral nerve recording device with axon‐dimension, cuff‐less microneedle electrode array | |
| Lee et al. | Nanoenabled direct contact interfacing of syringe-injectable mesh electronics | |
| Pothof et al. | Chronic neural probe for simultaneous recording of single-unit, multi-unit, and local field potential activity from multiple brain sites | |
| US20150080695A1 (en) | Conformable Actively Multiplexed High-Density Surface Electrode Array for Brain Interfacing | |
| KR102140137B1 (en) | Deep brain stimulation transparent electrodes array and neural signal detection method using the same | |
| KR20130087202A (en) | Neuro device having nano wire and supporting layer | |
| Poppendieck et al. | Development, manufacturing and application of double-sided flexible implantable microelectrodes | |
| Khatib et al. | High-density soft bioelectronic fibres for multimodal sensing and stimulation | |
| US20240057943A1 (en) | Multilayer and bouquet fiber-based neural probes and methods of making and uses thereof | |
| Zhou et al. | Intraoperative Nerve Mapping and Visualization System: Optimal Neurological Function Preservation in Schwannoma Surgery | |
| Deng et al. | Minimally Invasive Micro‐Hole Intervention for Wireless Intracranial Pressure Measurement | |
| Liu et al. | Developing clinical grade flexible implantable electronics | |
| Byun et al. | Development of integrated flexible penetrating microelectrode array with interconnection cable for use in various nervous systems | |
| Kim et al. | Flexible thin film electrode arrays for minimally-invasive neurological monitoring | |
| 배재영 | Fully Biodegradable and Axis Transformable Soft Electronics for Minimally Invasive Brain Cortex Interfaces | |
| CN120616552A (en) | Minimally invasive electrocorticography brain-computer interface |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AS | Assignment |
Owner name: M.I.TECH CO., LTD., KOREA, REPUBLIC OF Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:PARK, SE-IK;CHANG, JIN-WOO;KIM, SUNG JUNE;AND OTHERS;SIGNING DATES FROM 20130410 TO 20130411;REEL/FRAME:030250/0939 |
|
| STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |